How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-α and Darbepoetin-α in 2001–3 and the Cost Implications for CMS

Author： Kanavos Panos G.  

Publisher： Adis International

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.13, Iss.6, 2005-01, pp. : 359-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Injury cost-analysis and ethics: At what costs?

By Rogmans W.  

Injury Control and Safety Promotion, Vol. 6, Iss. 1, 1999-03 ,pp. : 3-9

Taylor & Francis Ltd

Access to resources Recommend Favorite

How safe are childcare products, toys and playground equipment? A Swedish analysis of mild brain injuries at home and during leisure time 1998-1999

By Emanuelson I.  

Injury Control and Safety Promotion, Vol. 10, Iss. 3, 2003-09 ,pp. : 139-144

Taylor & Francis Ltd

Access to resources Recommend Favorite

Integration of Case and Disease Management: Why and How?

By Radzwill M.A.  

Disease Management & Health Outcomes, Vol. 10, Iss. 5, 2002-01 ,pp. : 277-289

Adis International

Access to resources Recommend Favorite

How reasonable is reasonable use? The search for safer stepladders

By Clift L.   Navarro T.B.   Thomas D.A.B.  

Injury Control and Safety Promotion, Vol. 9, Iss. 3, 2002-09 ,pp. : 175-184

Taylor & Francis Ltd

Access to resources Recommend Favorite

Screening for Depression in Patients with Chronic Illness: Why and How?

By Davis J.M.   Gershtein C.M.  

Disease Management & Health Outcomes, Vol. 11, Iss. 6, 2003-01 ,pp. : 375-378

Adis International

Access to resources Recommend Favorite